United Therapeutics Corporation (UTHR) — Net Asset Quality Index
United Therapeutics Corporation (UTHR) has a Net Asset Quality Index of 89.6% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $7.35 Billion minus total liabilities of $760.90 Million yields net assets of $6.59 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check UTHR cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
United Therapeutics Corporation Net Asset Quality Index Over Time (1998–2024)
This chart shows how United Therapeutics Corporation's Net Asset Quality Index has evolved across 27 annual periods from 1998 to 2024. As of September 2025, the index stands at 89.6%, representing net assets of $6.59 Billion against total assets of $7.35 Billion USD. See United Therapeutics Corporation (UTHR) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for United Therapeutics Corporation (1998–2024)
The table below presents the year-by-year Net Asset Quality Index for United Therapeutics Corporation from 1998 to 2024, covering 27 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see UTHR company net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 87.5% | $6.44 Billion | $7.36 Billion | $920.00 Million | ▲ +4.0 pp |
| 2023 | 83.5% | $5.98 Billion | $7.17 Billion | $1.18 Billion | ▲ +4.1 pp |
| 2022 | 79.4% | $4.80 Billion | $6.04 Billion | $1.25 Billion | ▲ +2.8 pp |
| 2021 | 76.6% | $3.96 Billion | $5.17 Billion | $1.21 Billion | ▲ +3.0 pp |
| 2020 | 73.6% | $3.40 Billion | $4.62 Billion | $1.22 Billion | ▲ +2.5 pp |
| 2019 | 71.0% | $2.78 Billion | $3.91 Billion | $1.13 Billion | ▼ -10.9 pp |
| 2018 | 82.0% | $2.79 Billion | $3.40 Billion | $612.40 Million | ▲ +9.0 pp |
| 2017 | 73.0% | $2.10 Billion | $2.88 Billion | $777.60 Million | ▼ -7.1 pp |
| 2016 | 80.1% | $1.86 Billion | $2.33 Billion | $463.40 Million | ▲ +6.8 pp |
| 2015 | 73.2% | $1.60 Billion | $2.18 Billion | $584.80 Million | ▲ +6.1 pp |
| 2014 | 67.2% | $1.27 Billion | $1.88 Billion | $618.84 Million | ▲ +4.7 pp |
| 2013 | 62.5% | $1.30 Billion | $2.09 Billion | $783.26 Million | ▼ -4.8 pp |
| 2012 | 67.3% | $1.09 Billion | $1.63 Billion | $531.73 Million | ▲ +4.8 pp |
| 2011 | 62.5% | $948.49 Million | $1.52 Billion | $569.59 Million | ▲ +0.7 pp |
| 2010 | 61.7% | $883.89 Million | $1.43 Billion | $547.75 Million | ▼ -0.4 pp |
| 2009 | 62.1% | $653.01 Million | $1.05 Billion | $398.54 Million | ▲ +3.8 pp |
| 2008 | 58.3% | $507.70 Million | $871.32 Million | $363.62 Million | ▲ +7.9 pp |
| 2007 | 50.4% | $295.79 Million | $587.02 Million | $291.23 Million | ▲ +7.6 pp |
| 2006 | 42.8% | $204.61 Million | $478.55 Million | $273.94 Million | ▼ -51.6 pp |
| 2005 | 94.4% | $275.10 Million | $291.41 Million | $16.31 Million | ▲ +1.9 pp |
| 2004 | 92.5% | $191.64 Million | $207.16 Million | $15.52 Million | ▼ -1.0 pp |
| 2003 | 93.5% | $167.76 Million | $179.50 Million | $11.74 Million | ▲ +0.5 pp |
| 2002 | 93.0% | $171.66 Million | $184.57 Million | $12.91 Million | ▲ +0.4 pp |
| 2001 | 92.6% | $196.40 Million | $212.12 Million | $15.72 Million | ▼ -1.1 pp |
| 2000 | 93.7% | $234.74 Million | $250.64 Million | $15.91 Million | ▲ +4.2 pp |
| 1999 | 89.5% | $53.60 Million | $59.90 Million | $6.30 Million | ▲ +0.2 pp |
| 1998 | 89.3% | $16.70 Million | $18.70 Million | $2.00 Million | — |